Advertisement

The Scientist

» biotechnology and immunology

Most Recent

image: It’s in the Genes

It’s in the Genes

By | October 24, 2013

Researchers find strong correlations between the composition of the human microbiome and genetic variation in immune-related pathways.

4 Comments

image: Company Size Won’t Predict Success

Company Size Won’t Predict Success

By | October 23, 2013

New analysis finds that the size of a company is not tied to getting a drug to market.

0 Comments

image: Drug Widens Immunity to Flu

Drug Widens Immunity to Flu

By | October 20, 2013

An immune suppressive drug can unexpectedly help immunized mice fight off many strains of flu.

0 Comments

image: Venter’s New Digs

Venter’s New Digs

By | October 9, 2013

Genomics pioneer Craig Venter is building a new campus for his non-profit research institute right next to his alma mater in San Diego.

0 Comments

image: Building 3-D Microbial Communities

Building 3-D Microbial Communities

By | October 7, 2013

Researchers apply a 3-D printing technique to structure populations of bacteria in a three-dimensional environment.

0 Comments

image: Criminal Hype

Criminal Hype

By | September 25, 2013

Overstating the benefits of a drug lands a former biotech executive in home detention.

0 Comments

image: Remaking a Classic

Remaking a Classic

By | September 1, 2013

Companies are bursting at the seams with tools to engineer pharma’s next magic bullet: the new and improved antibody.

0 Comments

image: Week in Review: August 26–30

Week in Review: August 26–30

By | August 30, 2013

New model for neurodevelopment; more biotechs going public; how a virus jumped from mammals to birds; statin side effect linked to genetic variant

0 Comments

image: Biotech IPOs Surge

Biotech IPOs Surge

By | August 23, 2013

The drought has ended for biotech companies seeking to join the public market, but whether this upward swing will last is anybody’s guess.

0 Comments

image: Opinion: Racing Toward Invention

Opinion: Racing Toward Invention

By | July 23, 2013

A newly instated patent law discriminates against academics and small biotechs.

6 Comments

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

  4. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

Advertisement
Lexogen
Lexogen
Advertisement
Life Technologies